Medical Research News

RSS

Mindfulness-based behavioral therapy changes brain responses to reduce opioid cravings

Mindfulness-Oriented Recovery Enhancement (MORE), a behavioral therapy used alongside medication treatment, may help people with opioid use disorder respond differently to drug-related cues and natural rewards, according to a randomized clinical trial led by researchers at the Icahn School of Medicine at Mount Sinai.

28 Oct 2026

Michigan Medicine study reveals how diabetes drug reduces stroke risk

For millions living with type 2 diabetes, heart disease remains one of the greatest threats to their health.

28 Oct 2026

Brain development eliminates flawed neurons to ensure genomic integrity

During fetal development, the human brain generates an excess of neurons, most of which are eliminated shortly before and after birth.

28 Oct 2026

Prefrontal cortex activity fails to predict individual emotion regulation

A supervisor criticizes a report in front of the entire team – you feel exposed and hurt. But if you tell yourself, "She takes my work seriously and wants the project to succeed," the same situation can lose some of its intensity. In psychology, this deliberate reinterpretation is called cognitive reappraisal.

28 Oct 2026

Landmark studies map how genetic differences drive human diseases

In three landmark studies published in Nature today, Australian researchers have made major advances in our understanding of how genetic differences between people influence disease.

28 Oct 2026

Nicotine pouches gain rapid popularity among adult tobacco users

A national survey study conducted by the University of Cincinnati found that nicotine pouch use increased sharply in the United States between 2021 and 2024 among adult tobacco users.

28 Oct 2026

Study identifies common mechanism behind widespread cancer mutations

A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.

28 Oct 2026

New score predicts thrombosis risk in hospitalized pancreatitis patients

Professor Julia Mayerle and colleagues from LMU University Hospital Munich have developed an admission-based score intended to identify pancreatitis patients more likely to be diagnosed with thrombosis during hospitalization.

28 Oct 2026

Engineered albumin could lead to needle-free, long-lasting protein medicines

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream.

28 Oct 2026

Plant and animal proteins show opposite effects on testosterone levels

Higher animal protein intake was associated with lower blood testosterone levels, while higher plant protein intake was associated with higher levels, according to a new study from the University of Eastern Finland.

28 Oct 2026

Review highlights essential neurological considerations for gender dysphoria care

Gender dysphoria involves distress caused by a mismatch between a person's gender identity and sex assigned at birth.

28 Oct 2026

Overcoming cancer stigma requires policy changes and public education

Cancer-related discrimination arises from long-lasting cultural and institutional misconceptions, with significant impacts on every part of a person's quality of life and health – and Flinders University researchers say it requires coordinated policy, legal, institutional and public education responses for change to occur.

28 Oct 2026

DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced an investment by DEBRA Research in Topadur to support a preclinical program exploring a new treatment approach for dystrophic Epidermolysis bullosa (DEB). DEB is one of the more severe forms of EB, characterized by extremely fragile skin and progressive, debilitating complications.

28 Oct 2026

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines.

From Adalvo 28 Oct 2026

Alcami announces promotion of Robert Tragas to Vice President, Laboratory Services

Alcami, a leading contract development and manufacturing organization (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to Vice President, Laboratory Services.

28 Oct 2026

Prolific announces major new investments and partnerships with NantWorks and Zylidac Bio CDMO

On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to scale up the production of Prolific's Optogentics-enabled cell lines for clinical and GMP manufacturing!

From Prolific Machines, Inc. 28 Oct 2026

NIOX® launches NIOX PRO®, their next generation FeNO testing device

NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other inflammatory airway diseases.

From NIOX Group PLC 28 Oct 2026

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.

From Atelerix Ltd 28 Oct 2026

Novel peptide from red alga shows potential for blood glucose control

It is a dietary staple found in sushi, rice wraps, and ramen toppings. Commonly known as nori in Japan and gim in Korea, red seaweed is especially popular across Asia.

27 Oct 2026

Climate change intensifies global health risks, Lancet Countdown report warns

The 2026 Report of the Lancet Countdown on Health and Climate Change finds that many of the health risks and harms of climate change grew faster in the decade since the Paris Agreement was introduced (2016–2025) than in the decade before it (2006–2015).

27 Oct 2026